-
Dr Hamid5yrSerotonin syndrome- , physicians need to be aware of this entity, for timely diagnosis and prompt treatment -
Huma Sheikh, CEO, NY Neurology Medicine, PC5yrThis is concerning.
Phenome-wide analysis highlights putative causal relationships between self-reported migraine and other complex traits - The Journal of Headache and Pain
Source : https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-021-01284-w
Background Migraine is a complex neurological disorder that is considered the most common disabling brain disorder affecting 14 % of people worldwide. The present study sought to infer potential causal relationships...
-
Huma Sheikh, CEO, NY Neurology Medicine, PC5yrThere are a lot of things that can complicate migraine.
Dietary alteration of n-3 and n-6 fatty acids for headache reduction in adults with migraine: randomized controlled trial
Source : https://www.bmj.com/content/374/bmj.n1448.full
Objective To determine whether dietary interventions that increase n-3 fatty acids with and without reduction in n-6 linoleic acid can alter circulating lipid mediators implicated in headache pathogenesis, and decrease...
-
Dr Hamid5yrH3-L6 and H3 interventions altered bioactive mediators implicated in headache pathogenesis and decreased frequency and severity of headaches, but did not significantly improve quality of life -
Huma Sheikh, CEO, NY Neurology Medicine, PC5yrThis may help to clarify why keto diets may help some patients with migraine.
Vestibular Migraine and Tinnitus: A Challenging Narrative
Source : https://www.cureus.com/articles/61216-vestibular-migraine-and-tinnitus-a-challenging-narrative
Vestibular migraine (VM) is one of the most common types of episodic vertigo. Over the last 11 years, this disorder has been studied by both neurologists and otolaryngologists. Based on...
-
Huma Sheikh, CEO, NY Neurology Medicine, PC5yrChallenging indeed, vestibular migraine is difficult to diagnose and can be very challenging to treat.
Extreme ecchymoses in a migraine patient using concomitant treatment with calcitonin gene-related peptide receptor antibodies and fish oil supplements: a case report
Source : https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-021-02294-6
Background Erenumab, a monoclonal antibody against the calcitonin gene-related peptide (CGRP) receptor, is registered for migraine prevention. Compared to other conventional migraine prevention medicines (i.e. topiramate, betablockers and amitriptyline) erenumab...
-
Huma Sheikh, CEO, NY Neurology Medicine, PC5yrimportant reminder to ask about supplements.